Partnerships for Global Health Success: Spotlight on USAID
Breakfast/Registration: 9:00 - 9:30 AM
Panel Discussion: 9:30 - 11:00 AM
While the U.S. Agency for International Development (USAID) celebrates its 50th anniversary as the principal U.S. agency for humanitarian relief and international development efforts, it is important to recognize the impact the Agency has had on global health research and development (R&D).
In addition to making global health gains overseas, USAID's work in R&D has had a positive health and economic impact here at home and has proven a valuable investment in this time of economic constraint. Public-private partnerships have been vital to USAID's success in improving and saving the lives of millions of people around the world. Partnerships in global health R&D leverage multiple sources of funding and expertise to accelerate the discovery and development of health technologies. The value of these collaborations lies in their ability to capitalize on the strengths of each partner in efficient, innovative, and cost-saving ways.
Join us for a conversation with USAID and some of its global health R&D partners from both the public and private sectors for insight into how partnerships have been instrumental to the Agency's work in global health, as well as the impact of its work on the American economy and our health.
- Hugh Chang Director of Special Initiatives, PATH
- Rick King Vice President, Vaccine Design, IAVI
- Emily Moore Vice President for Business Development, Temptime Corp.
- Wendy Taylor Senior Advisor for Innovative Finance and Public Private Partnerships, Bureau of Global Health, USAID
Moderator: Susan Dentzer, Editor-in-Chief, Health Affairs
For those who cannot attend in person, the event will be webcast live at http://bit.ly/vWwx9o where we encourage you to submit questions. You can also join the conversation on Twitter under the hashtag #GHPDP.
Breakfast will be served before the panel discussion.